Five novel coding variants in genes not previously implicated in IBD were identified, along with 6 independently associated novel exonic variants in genes previously known to harbor mutations underpinning CD or IBD risk (2 of which were in NOD2). Here, NOD2 is linked to inflammatory bowel disease.